Oaktree Acquisition Corp. II
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OACB and buy or sell other stocks, ETFs, and their options commission-free!About OACB
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates.
CEOVilhelm Róbert Wessman
CEOVilhelm Róbert Wessman
Employees1,032
Employees1,032
HeadquartersLuxembourg, Luxembourg
HeadquartersLuxembourg, Luxembourg
Founded2021
Founded2021
Employees1,032
Employees1,032
OACB Key Statistics
Market cap2.83B
Market cap2.83B
Price-Earnings ratio19.89
Price-Earnings ratio19.89
Dividend yield—
Dividend yield—
Average volume503.37K
Average volume503.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.70
52 Week high$13.70
52 Week low$4.32
52 Week low$4.32
Stock Snapshot
With a market cap of 2.83B, Oaktree Acquisition Corp. II(OACB) trades at $9.38. The stock has a price-to-earnings ratio of 19.89.
On 2026-01-07, Oaktree Acquisition Corp. II(OACB) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 503.37K.
The stock's 52-week range extends from a low of $4.32 to a high of $13.70.
The stock's 52-week range extends from a low of $4.32 to a high of $13.70.
People also own
Based on the portfolios of people who own OACB. This list is generated using Robinhood data, and it’s not a recommendation.